← brief for 2026-10-19 · Slowing decline

Phase 1, open-label, randomized study of the elecoglipron pharmacokinetic profile in healthy participants under fed and fasted conditions.

Article B Peer reviewed Small trial

Key takeaways

This small trial tested a new diabetes drug in 14 healthy people. It measured how the drug moved through the body after eating or fasting. The study was short, lasting only a few days. It shows the drug is safe in this small group, but it does not test if the drug helps with diabetes.

Who did this work

Xu J · Haggag A · Butcher L · Liu H · Chen W · Sun X · Jha A · Yu H · Khan A · Parker VER · Tannergren C · Pan X

Source

Article · PubMed, the drug frontier · 2026 Oct 19
https://pubmed.ncbi.nlm.nih.gov/42896872/